- Home
- EPIX vs ICCM Comparison
EPIX vs ICCM Comparison
Compare EPIX & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPIX
- ICCM
- Stock Information
- Founded
- EPIX 2009
- ICCM 2006
- Country
- EPIX Canada
- ICCM Israel
- Employees
- EPIX N/A
- ICCM N/A
- Industry
- EPIX Biotechnology: Pharmaceutical Preparations
- ICCM
- Sector
- EPIX Health Care
- ICCM
- Exchange
- EPIX Nasdaq
- ICCM Nasdaq
- Market Cap
- EPIX 65.3M
- ICCM 70.1M
- IPO Year
- EPIX N/A
- ICCM N/A
- Fundamental
- Price
- EPIX $1.79
- ICCM $1.13
- Analyst Decision
- EPIX Hold
- ICCM Strong Buy
- Analyst Count
- EPIX 3
- ICCM 1
- Target Price
- EPIX $2.00
- ICCM $2.50
- AVG Volume (30 Days)
- EPIX 186.2K
- ICCM 238.0K
- Earning Date
- EPIX 05-13-2025
- ICCM 05-27-2025
- Dividend Yield
- EPIX N/A
- ICCM N/A
- EPS Growth
- EPIX N/A
- ICCM N/A
- EPS
- EPIX N/A
- ICCM N/A
- Revenue
- EPIX N/A
- ICCM $3,291,000.00
- Revenue This Year
- EPIX N/A
- ICCM $97.02
- Revenue Next Year
- EPIX N/A
- ICCM $212.86
- P/E Ratio
- EPIX N/A
- ICCM N/A
- Revenue Growth
- EPIX N/A
- ICCM 1.92
- 52 Week Low
- EPIX $1.40
- ICCM $0.48
- 52 Week High
- EPIX $7.88
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- EPIX 69.44
- ICCM 42.72
- Support Level
- EPIX $1.42
- ICCM $1.09
- Resistance Level
- EPIX $1.88
- ICCM $1.18
- Average True Range (ATR)
- EPIX 0.10
- ICCM 0.08
- MACD
- EPIX 0.03
- ICCM 0.00
- Stochastic Oscillator
- EPIX 81.32
- ICCM 35.71
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.